Transcriptome of HPβCD-treated Niemann-pick disease type C1 cells highlights GPNMB as a biomarker for therapeutics.

The rare, fatal neurodegenerative disorder Niemann-Pick disease type C1 (NPC1) arises from lysosomal accumulation of unesterified cholesterol and glycosphingolipids. These subcellular pathologies lead to phenotypes of hepatosplenomegaly, neurological degeneration and premature death. The timing and severity of NPC1 clinical presentation is extremely heterogeneous. This study analyzed RNA-Seq data from 42 NPC1 patient-derived, primary fibroblast cell lines to determine transcriptional changes induced by treatment with 2-hydroxypropyl-β-cyclodextrin (HPβCD), a compound currently under investigation in clinical trials. A total of 485 HPβCD-responsive genes were identified. Pathway enrichment analysis of these genes showed significant involvement in cholesterol and lipid biosynthesis. Furthermore, immunohistochemistry of the cerebellum as well as measurements of serum from Npc1m1N null mice treated with HPβCD and adeno-associated virus (AAV) gene therapy suggests that one of the identified genes, GPNMB, may serve as a useful biomarker of treatment response in NPC1 disease. Overall, this large NPC1 patient-derived dataset provides a comprehensive foundation for understanding the genomic response to HPβCD treatment.

• Publication year

  2021

• Venue

  Human Molecular Genetics

• Publication date

  2021-07-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/hmg/ddab194PMID 34296265PMCID PMC8643505
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intracerebroventricular Treatment with 2-Hydroxypropyl-β-Cyclodextrin Decreased Cerebellar and Hepatic Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Expression in Niemann–Pick Disease Type C Model Mice

  2021cited by this paper
• Monitoring the itinerary of lysosomal cholesterol in Niemann-Pick Type C1-deficient cells after cyclodextrin treatment[S]

  2020cited by this paper
• Changes in global gene expression indicate disordered autophagy, apoptosis and inflammatory processes and downregulation of cytoskeletal signalling and neuronal development in patients with Niemann–Pick C disease

  2020cited by this paper
• Application of N-palmitoyl-O-phosphocholineserine for diagnosis and assessment of response to treatment in Niemann-Pick type C disease.

  2020cited by this paper
• Delineation of metabolic responses of Npc1-/-nih mice lacking the cholesterol-esterifying enzyme SOAT2 to acute treatment with 2-hydroxypropyl-β-cyclodextrin.

  2020cited by this paper
• Understanding and Treating Niemann–Pick Type C Disease: Models Matter

  2020cited by this paper
• The Lysosome at the Intersection of Cellular Growth and Destruction.

  2020cited by this paper
• 2-Hydroxypropyl-gamma-cyclodextrin overcomes NPC1 deficiency by enhancing lysosome-ER association and autophagy

  2020cited by this paper
• Transgenic Overexpression of GPNMB Protects Against MPTP-Induced Neurodegeneration

  2020cited by this paper
• PCSK9 Inhibition: Insights From Clinical Trials and Future Prospects

  2020cited by this paper
• Cholesterol Handling in Lysosomes and Beyond.

  2020cited by this paper
• Long‐term survival outcomes of patients with Niemann‐Pick disease type C receiving miglustat treatment: A large retrospective observational study

  2020cited by this paper
• Nutrient Signaling and Lysosome Positioning Crosstalk Through a Multifunctional Protein, Folliculin

  2020cited by this paper
• TFEB Transcriptional Responses Reveal Negative Feedback by BHLHE40 and BHLHE41.

  2020cited by this paper
• Glycoprotein nonmetastatic melanoma protein B: A key mediator and an emerging therapeutic target in autoimmune diseases

  2020cited by this paper
• Identification of Novel Pathways Associated with Patterned Cerebellar Purkinje Neuron Degeneration in Niemann-Pick Disease, Type C1

  2019cited by this paper
• NPC intracellular cholesterol transporter 1 (NPC1)-mediated cholesterol export from lysosomes

  2019cited by this paper
• Cyclodextrin triggers MCOLN1-dependent endo-lysosome secretion in Niemann-Pick type C cells[S]

  2019cited by this paper
• Proprotein convertase subtilisin/kexin type 9 and lipid metabolism

  2019cited by this paper
• Tissue-specific sex-differences in human gene expression.

  2019cited by this paper
• Insights into the Molecular Mechanisms of Cholesterol Binding to the NPC1 and NPC2 Proteins.

  2019cited by this paper
• Lysosomes as dynamic regulators of cell and organismal homeostasis

  2019cited by this paper
• Laboratory diagnosis of the Niemann-Pick type C disease: an inherited neurodegenerative disorder of cholesterol metabolism

  2019cited by this paper
• Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype

  2019cited by this paper
• Mechanisms and regulation of cholesterol homeostasis

  2019cited by this paper
• Pulmonary involvement in Niemann-Pick C type 1

  2018cited by this paper
• The glycoprotein GPNMB attenuates astrocyte inflammatory responses through the CD44 receptor

  2018cited by this paper
• Consensus clinical management guidelines for Niemann-Pick disease type C

  2018cited by this paper
• Validating glycoprotein non-metastatic melanoma B (gpNMB, osteoactivin), a new biomarker of Gaucher disease.

  2018cited by this paper
• Glycoprotein Non-Metastatic Protein B: An Emerging Biomarker for Lysosomal Dysfunction in Macrophages

  2018cited by this paper
• Glycoprotein NMB: a novel Alzheimer’s disease associated marker expressed in a subset of activated microglia

  2018cited by this paper
• Hydroxypropyl-beta and -gamma cyclodextrins rescue cholesterol accumulation in Niemann–Pick C1 mutant cell via lysosome-associated membrane protein 1

  2018cited by this paper
• Lysosomal storage diseases

  2018cited by this paper
• The glycoprotein GPNMB is selectively elevated in the substantia nigra of Parkinson's disease patients and increases after lysosomal stress.

  2018cited by this paper
• AAV9 intracerebroventricular gene therapy improves lifespan, locomotor function and pathology in a mouse model of Niemann–Pick type C1 disease

  2018cited by this paper
• Age, gender and UV-exposition related effects on gene expression in in vivo aged short term cultivated human dermal fibroblasts

  2017cited by this paper
• Methyl-β-cyclodextrin restores impaired autophagy flux in Niemann-Pick C1-deficient cells through activation of AMPK

  2017cited by this paper
• The landscape of sex-differential transcriptome and its consequent selection in human adults

  2017cited by this paper
• Determination of serum cholestane-3β,5α,6β-triol by gas chromatography-mass spectrometry for identification of Niemann-Pick type C (NPC) disease.

  2017cited by this paper
• Quantitation of plasmatic lysosphingomyelin and lysosphingomyelin-509 for differential screening of Niemann-Pick A/B and C diseases.

  2017cited by this paper
• Niemann-Pick disease type C in the newborn period: a single-center experience

  2017cited by this paper
• Increased brain expression of GPNMB is associated with genome wide significant risk for Parkinson’s disease on chromosome 7p15.3

  2017cited by this paper
• Emerging Roles for the Lysosome in Lipid Metabolism.

  2017cited by this paper
• Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial.

  2017cited by this paper
• Cyclodextrin has conflicting actions on autophagy flux in vivo in brains of normal and Alzheimer model mice

  2017cited by this paper
• LC-MS/MS multiplex analysis of lysosphingolipids in plasma and amniotic fluid: A novel tool for the screening of sphingolipidoses and Niemann-Pick type C disease

  2017cited by this paper
• Glycoprotein NMB: an Emerging Role in Neurodegenerative Disease

  2017cited by this paper
• AAV9-NPC1 significantly ameliorates Purkinje cell death and behavioral abnormalities in mouse NPC disease[S]

  2017cited by this paper
• GPNMB Induces BiP Expression by Enhancing Splicing of BiP Pre-mRNA during the Endoplasmic Reticulum Stress Response

  2017cited by this paper
• Identification of novel bile acids as biomarkers for the early diagnosis of Niemann‐Pick C disease

  2016cited by this paper
• Systemic AAV9 gene therapy improves the lifespan of mice with Niemann-Pick disease, type C1

  2016cited by this paper
• Heat shock protein–based therapy as a potential candidate for treating the sphingolipidoses

  2016cited by this paper
• Modelling TFE renal cell carcinoma in mice reveals a critical role of WNT signaling

  2016cited by this paper
• Untangling the brain's neuroinflammatory and neurodegenerative transcriptional responses

  2016cited by this paper
• Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming

  2016cited by this paper
• Cyclodextrins as Emerging Therapeutic Tools in the Treatment of Cholesterol-Associated Vascular and Neurodegenerative Diseases

  2016cited by this paper
• Gpnmb Is a Potential Marker for the Visceral Pathology in Niemann-Pick Type C Disease

  2016cited by this paper
• Efficacy and ototoxicity of different cyclodextrins in Niemann–Pick C disease

  2016cited by this paper
• Comprehensive Evaluation of Plasma 7-Ketocholesterol and Cholestan-3β,5α,6β-Triol in an Italian Cohort of Patients Affected by Niemann-Pick Disease due to NPC1 and SMPD1 Mutations.

  2016cited by this paper
• Cerebrospinal Fluid Calbindin D Concentration as a Biomarker of Cerebellar Disease Progression in Niemann-Pick Type C1 Disease

  2016cited by this paper
• Reversal of Pathologic Lipid Accumulation in NPC1-Deficient Neurons by Drug-Promoted Release of LAMP1-Coated Lamellar Inclusions

  2016cited by this paper
• Development of a bile acid–based newborn screen for Niemann-Pick disease type C

  2016cited by this paper
• Elevation of glycoprotein nonmetastatic melanoma protein B in type 1 Gaucher disease patients and mouse models

  2016cited by this paper
• Genetic and Chemical Activation of TFEB Mediates Clearance of Aggregated α-Synuclein

  2015cited by this paper
• Complex lipid trafficking in Niemann-Pick disease type C

  2015cited by this paper
• Identification of a Biomarker in Cerebrospinal Fluid for Neuronopathic Forms of Gaucher Disease

  2015cited by this paper
• The Longitudinal Transcriptomic Response of the Substantia Nigra to Intrastriatal 6-Hydroxydopamine Reveals Significant Upregulation of Regeneration-Associated Genes

  2015cited by this paper
• Long term follow-up to evaluate the efficacy of miglustat treatment in Italian patients with Niemann-Pick disease type C

  2015cited by this paper
• In Utero Diagnosis of Niemann-Pick Type C in the Absence of Family History.

  2015cited by this paper
• Lysosomal Stress in Obese Adipose Tissue Macrophages Contributes to MITF-Dependent Gpnmb Induction

  2014cited by this paper
• Mutation in osteoactivin decreases bone formation in vivo and osteoblast differentiation in vitro.

  2014cited by this paper
• Lysosome: regulator of lipid degradation pathways

  2014cited by this paper
• Niemann-Pick C disease and mobilization of lysosomal cholesterol by cyclodextrin

  2014cited by this paper
• Novel roles for the MiTF/TFE family of transcription factors in organelle biogenesis, nutrient sensing, and energy homeostasis

  2014cited by this paper
• Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

  2014cited by this paper
• Plasma Signature of Neurological Disease in the Monogenetic Disorder Niemann-Pick Type C*

  2014cited by this paper
• A new simple and rapid LC-ESI-MS/MS method for quantification of plasma oxysterols as dimethylaminobutyrate esters. Its successful use for the diagnosis of Niemann-Pick type C disease.

  2014cited by this paper
• Cholesterol homeostatic responses provide biomarkers for monitoring treatment for the neurodegenerative disease Niemann-Pick C1 (NPC1).

  2014cited by this paper
• Genetic and Chemical Correction of Cholesterol Accumulation and Impaired Autophagy in Hepatic and Neural Cells Derived from Niemann-Pick Type C Patient-Specific iPS Cells

  2014cited by this paper
• Diagnosis of Niemann-Pick disease type C with 7-ketocholesterol screening followed by NPC1/NPC2 gene mutation confirmation in Chinese patients

  2014cited by this paper
• A somatic cell defect is associated with the onset of neurological symptoms in a lysosomal storage disease.

  2013cited by this paper
• Impaired autophagy in the lipid-storage disorder Niemann-Pick type C1 disease.

  2013cited by this paper
• hLGDB: a database of human lysosomal genes and their regulation

  2013cited by this paper
• featureCounts: an efficient general purpose program for assigning sequence reads to genomic features

  2013cited by this paper
• Niemann-Pick diseases.

  2013cited by this paper
• Neuroprotection by cyclodextrin in cell and mouse models of Alzheimer disease

  2012cited by this paper
• Miglustat Improves Purkinje Cell Survival and Alters Microglial Phenotype in Feline Niemann-Pick Disease Type C

  2012cited by this paper
• Impaired proteolysis underlies autophagic dysfunction in Niemann-Pick type C disease.

  2012cited by this paper
• Cyclodextrin mediates rapid changes in lipid balance in Npc1−/− mice without carrying cholesterol through the bloodstream[S]

  2012cited by this paper
• Disruption and therapeutic rescue of autophagy in a human neuronal model of Niemann Pick type C1.

  2012cited by this paper
• Genomic Expression Analyses Reveal Lysosomal, Innate Immunity Proteins, as Disease Correlates in Murine Models of a Lysosomal Storage Disorder

  2012cited by this paper
• Quantitative Proteomic Analysis of Niemann-Pick Disease, Type C1 Cerebellum Identifies Protein Biomarkers and Provides Pathological Insight

  2012cited by this paper
• Normalization of Cholesterol Homeostasis by 2-Hydroxypropyl-β-cyclodextrin in Neurons and Glia from Niemann-Pick C1 (NPC1)-deficient Mice*

  2012cited by this paper
• Microarray expression analysis and identification of serum biomarkers for Niemann-Pick disease, type C1.

  2012cited by this paper
• Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways.

  2011cited by this paper
• Alteration of Gene Expression Profile in Niemann-Pick Type C Mice Correlates with Tissue Damage and Oxidative Stress

  2011cited by this paper
• A sensitive and specific LC-MS/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma[S]

  2011cited by this paper
• The melanoma‐associated transmembrane glycoprotein Gpnmb controls trafficking of cellular debris for degradation and is essential for tissue repair

  2010cited by this paper
• Cyclodextrin Induces Calcium-Dependent Lysosomal Exocytosis

  2010cited by this paper
• Weekly cyclodextrin administration normalizes cholesterol metabolism in nearly every organ of the Niemann-Pick type C1 mouse and markedly prolongs life.

  2010cited by this paper

• From RAAS blockade to regenerative medicine: evolving treatment strategies in Alport syndrome

  2025cites this paper
• ApoE4 requires lipidation enhancement to resolve cellular lipid and protein abnormalities following NPC1 inhibition

  2025influential citation
• Cholesterol in the CNS: functions, recycling and remyelination

  2025cites this paper
• Advances in mass spectrometry of lipids for the investigation of Niemann-pick type C disease

  2025cites this paper
• Advances in research on potential therapeutic approaches for Niemann-Pick C1 disease

  2024cites this paper
• Regional Differences in the Small Intestinal Proteome of Control Mice and of Mice Lacking Lysosomal Acid Lipase

  2024cites this paper
• Differently increased volumes of multiple brain areas in Npc1 mutant mice following various drug treatments

  2024cites this paper
• Peripheral immune system modulates Purkinje cell degeneration in Niemann–Pick disease type C1

  2023cites this paper
• Glycoprotein non-metastatic protein B (GPNMB) plasma values in patients with chronic visceral acid sphingomyelinase deficiency.

  2023cites this paper
• MicroRNA Profile, Putative Diagnostic Biomarkers and RNA-Based Therapies in the Inherited Lipid Storage Disease Niemann-Pick Type C

  2023cites this paper
• Identification of cerebral spinal fluid protein biomarkers in Niemann-Pick disease, type C1

  2023cites this paper
• Glycoprotein Non-Metastatic Protein B (GPNMB): The Missing Link Between Lysosomes and Obesity

  2023cites this paper
• Progranulin and GPNMB: interactions in endo-lysosome function and inflammation in neurodegenerative disease

  2023cites this paper
• Severe neurometabolic phenotype in npc1−/− zebrafish with a C-terminal mutation

  2023cites this paper
• The Niemann-Pick type diseases - A synopsis of inborn errors in sphingolipid and cholesterol metabolism.

  2023cites this paper
• Cyclo™) demonstrates

  2022cites this paper
• Mass spectrometry-based proteomics in neurodegenerative lysosomal storage disorders.

  2022cites this paper
• Intravenous 2-hydroxypropyl-β-cyclodextrin (Trappsol® Cyclo™) demonstrates biological activity and impacts cholesterol metabolism in the central nervous system and peripheral tissues in adult subjects with Niemann-Pick Disease Type C1: Results of a phase 1 trial.

  2022cites this paper
• Cyclodextrins applied to the treatment of lysosomal disorders.

  2022cites this paper
• Correlation of age of onset and clinical severity in Niemann–Pick disease type C1 with lysosomal abnormalities and gene expression

  2022cites this paper